I have had those exact thoughts...for awhile that the lack of new and reports serves the interest of insiders (series B stockholders and investors yet named and deals yet to be announced....) and hopefully that has change with the reappoint of the some of the members...
ShortonCash Friday, 07/29/16 05:04:26 PM
Re: None
Post #
18477
of 24224 Go
Here's a thought... Holders of Series B stock....have a huge interest in the closing value of the stock...
The have the Dr in their pocket...
When they are done playing with the value of the stock then the news will come out...
Its really only them, and the Doc left. Everyone else ins in a different company different location.... No one sold any shares..that they did not buy back...
Notice there have not been any form 4 filed everyone in the know has kept their shares...
Some fiduciary duties to common shareholders has been bent to suit the groups that are left... failure to report new and forms...
but new will come out now that the stock has no when there's no room left for them do drive the price down and when they have completely loaded up on share to sell when new comes out...
IMO stick around the fun is about to begin again..News will be out soon.... and IMO a lot of it... And you will have to wonder where was that news before now...
The website is a joke and the accountant now controls the flow of information going out... how convenient wonder who's payroll he is on.
From the prior dealings..
. Holders of Series B have no redemption rights and each share of Series B is entitled to interest at a simple interest rate of 6% per annum. Series B is convertible, at the discretion of our management, into shares of our common stock, except that the holders of the Series B may elect to convert the Series B into common stock upon or after the resignation or termination of our Chief Executive Officer. The number of shares of common stock issuable upon conversion is calculated by (i) multiplying the number of Series B being converted by the per share purchase price received by the Company for such Series B , and then, multiplying such number by 130% and then dividing this calculated value by the average closing bid price, as defined, or by (ii) first, allocating the Series B proportionately according to the amounts by date of individual cash tranches received by the Company then, second, multiplying the number of Series B being converted, identified by tranche, by the per share purchase price received by the Company for such Series B, and then, multiplying such number or numbers by 130% and, finally, dividing the calculated value(s) by the average closing bid price, as defined. We have the right to redeem the Series B in cash at the face amount plus any accrued, but unpaid dividends.
